CervoMed’s stock rises as FDA grants orphan drug status to dementia drug
There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.
There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.
What's Your Reaction?
